A standardized core set for systemic sclerosis clinical trials. First step in development of combined response index

Rheumatology

Volumn 47, Issue SUPPL. 5, 2009, Pages

  Khanna, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trials; Combined Response Index; Provisional core set; Response measure; Scleroderma; Systemic sclerosis

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; HUMAN; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

EID: 69949120584     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken266     Document Type: Conference Paper

References (11)

1. Altman RD, Medsger TA Jr, Bloch DA et al. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
2. Khanna D, Merkel PA. Outcome measures in systemic sclerosis: An update on instruments and current research. Curr Rheumatol Rep 2007;9:151-7.
3. Baroni SS, Santillo M, Bevilacqua F et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006;354:2667-76.
4. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
5. Giannini EH, Ruperto N, Ravelli A et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
6. Khanna D, Lovell DJ, Giannini E et al. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 2008;67:703-9.
7. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
8. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
9. Fries JF, Spitz P, Kraines RG et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
10. Ware J, Kosinski M, Dewey J. How to score version two of the SF-36 Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.
11. Merkel PA, Herlyn K, Martin RW et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 2002;46:2410-20.